Founded in 1946 Grindeks celebrates 75th anniversary in 2021. Today we are the leading pharmaceutical manufacturer in the Baltic States, headquartered in Riga, Latvia. Grindeks Group consists of 4 subsidiaries with manufacturing plants in Latvia, Estonia and Slovakia.  Over the years we have been recognized for helping millions of patients worldwide.

Our products are sold in 90 countries globally. The most important export markets of Grindeks are the EU countries, Russia and other CIS countries, the USA, Canada and Japan.

Grindeks product portfolio is successfully composed of original products, generics and active pharmaceutical ingredients, all produced in line with the world-class requirements of safety and quality. To help people overcome the health issues, we focus on the heart and cardiovascular, CNS, anti-cancer and anti-diabetes medicines. We aim to improve people lives and make health solutions accessible to our patients.